Patient-Reported Outcomes with Cemiplimab Versus Chemotherapy in Advanced Non-Small Cell Lung Cancer (Ansclc): Geographic Region Subgroups in EMPOWER-Lung 1

Patient-Reported Outcomes with Cemiplimab Versus Chemotherapy in Advanced Non-Small Cell Lung Cancer (Ansclc): Geographic Region Subgroups in EMPOWER-Lung 1

Bilgi Bilgi
Nov 7, 2023 - 02:01 Güncelleme: Nov 7, 2023 - 02:07
0 188
Patient-Reported Outcomes with Cemiplimab Versus Chemotherapy in Advanced Non-Small Cell Lung Cancer (Ansclc): Geographic Region Subgroups in EMPOWER-Lung 1

Patient-Reported Outcomes with Cemiplimab Versus Chemotherapy in Advanced Non-Small Cell Lung Cancer (Ansclc): Geographic Region Subgroups in EMPOWER-Lung 1 Ho, G. F.; Sezer, A.; Kilickap, S.; Gumus, M.; Bondarenko, I.; Ozguroglu, M.; Gogishvili, M.; He, X.; Gullo, G.; Rietschel, P.; Quek, R. G.

Kaynak